rs72552034

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_021098.3(CACNA1H):​c.1047G>A​(p.Ser349Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00014 in 1,612,250 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00018 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00014 ( 2 hom. )

Consequence

CACNA1H
NM_021098.3 synonymous

Scores

2

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -8.07

Publications

4 publications found
Variant links:
Genes affected
CACNA1H (HGNC:1395): (calcium voltage-gated channel subunit alpha1 H) This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]
CACNA1H Gene-Disease associations (from GenCC):
  • hyperaldosteronism, familial, type IV
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • childhood absence epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • epilepsy, childhood absence, susceptibility to, 6
    Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.74).
BP6
Variant 16-1200499-G-A is Benign according to our data. Variant chr16-1200499-G-A is described in ClinVar as Likely_benign. ClinVar VariationId is 460038.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-8.07 with no splicing effect.
BS1
Variant frequency is greater than expected in population mid. GnomAdExome4 allele frequency = 0.000136 (198/1459944) while in subpopulation MID AF = 0.00694 (40/5766). AF 95% confidence interval is 0.00524. There are 2 homozygotes in GnomAdExome4. There are 103 alleles in the male GnomAdExome4 subpopulation. Median coverage is 34. This position passed quality control check.
BS2
High AC in GnomAd4 at 27 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1HNM_021098.3 linkc.1047G>A p.Ser349Ser synonymous_variant Exon 7 of 35 ENST00000348261.11 NP_066921.2 O95180-1B3KQH9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1HENST00000348261.11 linkc.1047G>A p.Ser349Ser synonymous_variant Exon 7 of 35 1 NM_021098.3 ENSP00000334198.7 O95180-1
CACNA1HENST00000569107.6 linkc.1047G>A p.Ser349Ser synonymous_variant Exon 7 of 34 1 ENSP00000454990.2 H3BNT0
CACNA1HENST00000711493.1 linkc.1047G>A p.Ser349Ser synonymous_variant Exon 7 of 34 ENSP00000518778.1
CACNA1HENST00000565831.7 linkc.1047G>A p.Ser349Ser synonymous_variant Exon 7 of 34 1 ENSP00000455840.1 O95180-2
CACNA1HENST00000711450.1 linkc.1047G>A p.Ser349Ser synonymous_variant Exon 7 of 35 ENSP00000518762.1
CACNA1HENST00000564231.6 linkc.1047G>A p.Ser349Ser synonymous_variant Exon 7 of 35 1 ENSP00000457555.2 H3BUA8
CACNA1HENST00000638323.1 linkc.1008G>A p.Ser336Ser synonymous_variant Exon 7 of 35 5 ENSP00000492267.1 A0A1W2PR14
CACNA1HENST00000562079.6 linkc.1047G>A p.Ser349Ser synonymous_variant Exon 7 of 34 1 ENSP00000454581.2 H3BMW6
CACNA1HENST00000711438.1 linkc.1008G>A p.Ser336Ser synonymous_variant Exon 7 of 34 ENSP00000518754.1
CACNA1HENST00000711482.1 linkc.1047G>A p.Ser349Ser synonymous_variant Exon 7 of 36 ENSP00000518771.1
CACNA1HENST00000711485.1 linkc.1047G>A p.Ser349Ser synonymous_variant Exon 7 of 35 ENSP00000518774.1
CACNA1HENST00000711455.1 linkc.1047G>A p.Ser349Ser synonymous_variant Exon 7 of 36 ENSP00000518768.1
CACNA1HENST00000711483.1 linkc.1047G>A p.Ser349Ser synonymous_variant Exon 7 of 35 ENSP00000518772.1
CACNA1HENST00000711456.1 linkc.1047G>A p.Ser349Ser synonymous_variant Exon 7 of 34 ENSP00000518769.1
CACNA1HENST00000621827.2 linkn.1047G>A non_coding_transcript_exon_variant Exon 7 of 37 6 ENSP00000518766.1
CACNA1HENST00000637236.3 linkn.1047G>A non_coding_transcript_exon_variant Exon 7 of 34 5 ENSP00000492650.2 A0A1W2PS38
CACNA1HENST00000639478.1 linkn.1047G>A non_coding_transcript_exon_variant Exon 7 of 35 5 ENSP00000491945.1 A0A1W2PQW2
CACNA1HENST00000640028.1 linkn.1047G>A non_coding_transcript_exon_variant Exon 7 of 35 5 ENSP00000491488.1 A0A1W2PQ19
CACNA1HENST00000711442.1 linkn.*494G>A non_coding_transcript_exon_variant Exon 6 of 34 ENSP00000518758.1
CACNA1HENST00000711448.1 linkn.1047G>A non_coding_transcript_exon_variant Exon 7 of 36 ENSP00000518760.1
CACNA1HENST00000711449.1 linkn.1047G>A non_coding_transcript_exon_variant Exon 7 of 35 ENSP00000518761.1
CACNA1HENST00000711451.1 linkn.1047G>A non_coding_transcript_exon_variant Exon 7 of 36 ENSP00000518763.1
CACNA1HENST00000711452.1 linkn.1047G>A non_coding_transcript_exon_variant Exon 7 of 36 ENSP00000518764.1
CACNA1HENST00000711453.1 linkn.1047G>A non_coding_transcript_exon_variant Exon 7 of 36 ENSP00000518765.1
CACNA1HENST00000711484.1 linkn.1047G>A non_coding_transcript_exon_variant Exon 7 of 35 ENSP00000518773.1
CACNA1HENST00000711486.1 linkn.1047G>A non_coding_transcript_exon_variant Exon 7 of 37 ENSP00000518775.1
CACNA1HENST00000711487.1 linkn.1047G>A non_coding_transcript_exon_variant Exon 7 of 36 ENSP00000518776.1
CACNA1HENST00000711488.1 linkn.1047G>A non_coding_transcript_exon_variant Exon 7 of 35 ENSP00000518777.1
CACNA1HENST00000711442.1 linkn.*494G>A 3_prime_UTR_variant Exon 6 of 34 ENSP00000518758.1

Frequencies

GnomAD3 genomes
AF:
0.000177
AC:
27
AN:
152188
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000217
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.000162
Gnomad OTH
AF:
0.000957
GnomAD2 exomes
AF:
0.000142
AC:
35
AN:
246924
AF XY:
0.000149
show subpopulations
Gnomad AFR exome
AF:
0.000130
Gnomad AMR exome
AF:
0.000145
Gnomad ASJ exome
AF:
0.000400
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000180
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000136
AC:
198
AN:
1459944
Hom.:
2
Cov.:
34
AF XY:
0.000142
AC XY:
103
AN XY:
726276
show subpopulations
African (AFR)
AF:
0.000120
AC:
4
AN:
33470
American (AMR)
AF:
0.000112
AC:
5
AN:
44708
Ashkenazi Jewish (ASJ)
AF:
0.000268
AC:
7
AN:
26108
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39692
South Asian (SAS)
AF:
0.000116
AC:
10
AN:
86256
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
51904
Middle Eastern (MID)
AF:
0.00694
AC:
40
AN:
5766
European-Non Finnish (NFE)
AF:
0.000103
AC:
115
AN:
1111702
Other (OTH)
AF:
0.000282
AC:
17
AN:
60338
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
11
22
34
45
56
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000177
AC:
27
AN:
152306
Hom.:
0
Cov.:
33
AF XY:
0.000201
AC XY:
15
AN XY:
74480
show subpopulations
African (AFR)
AF:
0.000217
AC:
9
AN:
41552
American (AMR)
AF:
0.000131
AC:
2
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5170
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10630
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.000162
AC:
11
AN:
68028
Other (OTH)
AF:
0.000947
AC:
2
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
2
3
5
6
8
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000902
Hom.:
0
Bravo
AF:
0.000170
EpiCase
AF:
0.000109
EpiControl
AF:
0.000296

ClinVar

Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Benign:1
Oct 14, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.74
CADD
Benign
0.30
DANN
Benign
0.85
PhyloP100
-8.1
Mutation Taster
=77/23
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.050
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs72552034; hg19: chr16-1250499; API